tiprankstipranks
Calliditas Therapeutics (CALT)
NASDAQ:CALT

Calliditas Therapeutics (CALT) Financial Statements

120 Followers

Calliditas Therapeutics Financial Overview

Calliditas Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.851; its P/E ratio is -20.91; Calliditas Therapeutics is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--kr 260.06Mkr 64.05Mkr 49.73M
Gross Profit--kr 255.73Mkr 61.66Mkr 49.12M
EBIT--kr -36.23Mkr -209.84Mkr -208.37M
EBITDA--kr -36.23Mkr -209.84Mkr -208.37M
Net Income Common Stockholders--kr -9.11Mkr -192.43Mkr -207.05M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 973.73Mkr 1.25Bkr 736.16Mkr 846.80Mkr 825.41M
Total Assetskr 1.86Bkr 1.95Bkr 1.52Bkr 1.46Bkr 1.34B
Total Debtkr 27.09Mkr 728.82Mkr 467.32Mkr 458.03Mkr 214.49M
Net Debtkr -946.64Mkr -520.27Mkr -268.84Mkr -388.77Mkr -610.92M
Total Liabilitieskr 1.52Bkr 1.20Bkr 792.17Mkr 737.20Mkr 473.20M
Stockholders Equitykr 334.81Mkr 766.26Mkr 725.94Mkr 721.09Mkr 871.14M
Cash Flow-
Free Cash Flow--kr -124.72Mkr -225.23Mkr -191.42M
Operating Cash Flow--kr -124.72Mkr -225.23Mkr -191.42M
Investing Cash Flow--kr -888.00Kkr -139.00Kkr -2.65M
Financing Cash Flow--kr -2.57Mkr 235.87Mkr 60.05M
Currency in SEK

Calliditas Therapeutics Earnings and Revenue History

Calliditas Therapeutics Debt to Assets

Calliditas Therapeutics Cash Flow

Calliditas Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis